These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 17101515)

  • 21. Effect of beta-cyclodextrin and hydroxypropyl beta-cyclodextrin complexation on physicochemical properties and antimicrobial activity of cefdinir.
    Aleem O; Kuchekar B; Pore Y; Late S
    J Pharm Biomed Anal; 2008 Jul; 47(3):535-40. PubMed ID: 18367363
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Characterization of ternary complexes of meloxicam-HPbetaCD and PVP or L-arginine prepared by the spray-drying technique.
    El-Maradny HA; Mortada SA; Kamel OA; Hikal AH
    Acta Pharm; 2008 Dec; 58(4):455-66. PubMed ID: 19103579
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Diloxanide furoate binary complexes with β-, methyl-β-, and hydroxypropyl-β-cyclodextrins: inclusion mode, characterization in solution and in solid state and in vitro dissolution studies.
    Aloisio C; Longhi M
    Pharm Dev Technol; 2018 Sep; 23(7):723-731. PubMed ID: 28758845
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The physicochemical characteristics and bioavailability of indomethacin from beta-cyclodextrin, hydroxyethyl-beta-cyclodextrin, and hydroxypropyl-beta-cyclodextrin complexes.
    Jambhekar S; Casella R; Maher T
    Int J Pharm; 2004 Feb; 270(1-2):149-66. PubMed ID: 14726131
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Enhanced oral bioavailability of acyclovir by inclusion complex using hydroxypropyl-β-cyclodextrin.
    Nair AB; Attimarad M; Al-Dhubiab BE; Wadhwa J; Harsha S; Ahmed M
    Drug Deliv; 2014 Nov; 21(7):540-7. PubMed ID: 24215288
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Solubility and release modulation effect of sulfamerazine ternary complexes with cyclodextrins and meglumine.
    Aloisio C; de Oliveira AG; Longhi M
    J Pharm Biomed Anal; 2014 Nov; 100():64-73. PubMed ID: 25129645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inclusion Complexation of Etodolac with Hydroxypropyl-beta-cyclodextrin and Auxiliary Agents: Formulation Characterization and Molecular Modeling Studies.
    Sherje AP; Kulkarni V; Murahari M; Nayak UY; Bhat P; Suvarna V; Dravyakar B
    Mol Pharm; 2017 Apr; 14(4):1231-1242. PubMed ID: 28248111
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparative analysis of binary and ternary cyclodextrin complexes with econazole nitrate in solution and in solid state.
    Jug M; Mennini N; Kövér KE; Mura P
    J Pharm Biomed Anal; 2014 Mar; 91():81-91. PubMed ID: 24444785
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Improvement of aripiprazole solubility by complexation with (2-hydroxy)propyl-β-cyclodextrin using spray drying technique.
    Mihajlovic T; Kachrimanis K; Graovac A; Djuric Z; Ibric S
    AAPS PharmSciTech; 2012 Jun; 13(2):623-31. PubMed ID: 22535520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Core-shell nanofibers of curcumin/cyclodextrin inclusion complex and polylactic acid: Enhanced water solubility and slow release of curcumin.
    Aytac Z; Uyar T
    Int J Pharm; 2017 Feb; 518(1-2):177-184. PubMed ID: 28057465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Thymol/cyclodextrin inclusion complex nanofibrous webs: Enhanced water solubility, high thermal stability and antioxidant property of thymol.
    Celebioglu A; Yildiz ZI; Uyar T
    Food Res Int; 2018 Apr; 106():280-290. PubMed ID: 29579928
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preparation and characterization of inclusion complexes of prazosin hydrochloride with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
    Liu L; Zhu S
    J Pharm Biomed Anal; 2006 Jan; 40(1):122-7. PubMed ID: 16095859
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulated dissolution rate from the inclusion complex of antichagasic benznidazole and cyclodextrin using hydrophilic polymer.
    Sá-Barreto LC; Gustmann PC; Garcia FS; Maximiano FP; Novack KM; Cunha-Filho MS
    Pharm Dev Technol; 2013; 18(5):1035-41. PubMed ID: 22200091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
    Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
    Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Multicomponent cyclodextrin system for improvement of solubility and dissolution rate of poorly water soluble drug.
    Patel M; Hirlekar R
    Asian J Pharm Sci; 2019 Jan; 14(1):104-115. PubMed ID: 32104443
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Binary inclusion complexes of diflunisal with β-cyclodextrin and hydroxypropyl-β-cyclodextrin: Preparation and characterization.
    Bashir M; Syed HK; Asghar S; Irfan M; Aslam N; Iqbal MS; Khan IU; Shah PA; Khan NR; Ahmad J; Saleem M; Asif M
    Pak J Pharm Sci; 2020 Sep; 33(5(Supplementary)):2307-2315. PubMed ID: 33832905
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Solubility and dissolution rate of progesterone-cyclodextrin-polymer systems.
    Lahiani-Skiba M; Barbot C; Bounoure F; Joudieh S; Skiba M
    Drug Dev Ind Pharm; 2006 Oct; 32(9):1043-58. PubMed ID: 17012117
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Drug/cyclodextrin solid systems in the design of hydrophilic matrices: a strategy to modulate drug delivery rate.
    Miro A; Quaglia F; Giannini L; Cappello B; La Rotonda MI
    Curr Drug Deliv; 2006 Oct; 3(4):373-8. PubMed ID: 17076639
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual Activity of Hydroxypropyl-β-Cyclodextrin and Water-Soluble Carriers on the Solubility of Carvedilol.
    Zoghbi A; Geng T; Wang B
    AAPS PharmSciTech; 2017 Nov; 18(8):2927-2935. PubMed ID: 28432614
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cyclodextrin-water soluble polymer ternary complexes enhance the solubility and dissolution behaviour of poorly soluble drugs. Case example: itraconazole.
    Taupitz T; Dressman JB; Buchanan CM; Klein S
    Eur J Pharm Biopharm; 2013 Apr; 83(3):378-87. PubMed ID: 23201048
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.